Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy (Q37589245)
Jump to navigation
Jump to search
scientific article published on 22 August 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy |
scientific article published on 22 August 2013 |
Statements
1 reference
Histone deacetylase inhibitors restore toxic BH3 domain protein expression in anoikis-resistant mammary and brain cancer stem cells, thereby enhancing the response to anti-ERBB1/ERBB2 therapy (English)
1 reference
Paul Dent
1 reference
Nichola Cruickshanks
1 reference
Hossein A Hamed
1 reference
Laurence Booth
1 reference
Seyedmehrad Tavallai
1 reference
Jahangir Syed
1 reference
Gangadharan B Sajithlal
1 reference
Steven Grant
1 reference
Andrew Poklepovic
1 reference
22 August 2013
1 reference
1 reference
982-996
1 reference
Identifiers
1 reference
1 reference
1 reference